The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New leadership moves, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Leadership Trends
See who's moving and how much in your market
No credit card required Weekly executive digest
Lexaria Bioscience Corp. Appoints Michael Shankman As Chief Financial Officer
PUBLIC · LEXXOct 01, 2024•over 1 year ago
Position
Chief Financial Officer
Company
Lexaria Bioscience
Michael Shankman
KelownaOtherBiotechnologyHealthcare
Description
Lexaria Bioscience Corp announces the appointment of Michael Shankman, CPA, as Chief Financial Officer (CFO) effective immediately. Mr Shankman will lead the Company's financial operations, bringing a wealth of financial and regulatory knowledge and experience to the executive team.
Company Information
Company
Lexaria Bioscience
Location
100 - 740 MCCURDY ROAD
Kelowna, British Columbia, Canada
About
Lexaria Bioscience Corp. is a global innovator in drug delivery platforms, focusing on improving the way active pharmaceutical ingredients (APIs) enter the bloodstream through oral delivery. The company has developed and investigated DehydraTECH with a variety of beneficial molecules in oral and topical formats, and operates a licensed in-house research laboratory. Additionally, the company holds a robust intellectual property portfolio with 39 patents granted and many patents pending worldwide.
KelownaOtherBiotechnologyHealthcare